Le Lézard
Classified in: Health, Science and technology
Subject: EXE

February Is Low Vision Awareness Month: If You Have Vision Loss, Apply For A Free Currency Reader Today Or Download The EyeNote® 3.0 Mobile App!


WASHINGTON, Jan. 30, 2018 /PRNewswire-USNewswire/ -- In observance of Low Vision Awareness Month, the Bureau of Engraving and Printing (BEP), in partnership with the Library of Congress' National Library Service for the Blind and Physically Handicapped (NLS), reminds the public about the U.S. Currency Reader Program, which provides assistive technology at no cost to eligible applicants.  The currency reader, called iBill®, is a small hand-held device that denominates all U.S. currency in circulation to assist people who are blind or visually impaired. 

EyeNote® 3.0 Mobile App

To date, more than 59,000 currency readers have been distributed to eligible U.S. citizens and legal residents.  "Over the years we have received extremely positive responses from the blind and visually impaired community, cash handlers, and business owners about the usefulness of the currency readers and mobile apps," said BEP Director Len Olijar.  "If you are blind or visually impaired, I encourage you to apply for a currency reader or download one of our mobile apps today.  And if you know someone who is blind or visually impaired, please let them know about this program."

The iBill® operates in one of three modes:  a clear natural voice, a pattern of tones, or a pattern of vibrations for privacy.  The vibration mode also assists people who are deaf and blind in identifying a note's denomination.  The device uses a single AAA battery, which is included.

To request a currency reader, individuals should complete the application located on BEP's website at http://www.bep.gov/uscurrencyreaderform.html or call (844) 815-9388, toll free, to request that an application be mailed. 

BEP also offers two mobile device applications that denominate currency by allowing users to scan a note and have the note's value communicated, EyeNote® and the IDEAL® Currency Identifier.  EyeNote 3.0®, our latest release, is 64-bit and compatible with Apple iOS 11 mobile applications; it can be downloaded free from the Apple App Store.  The IDEAL® Currency Identifier app for Android devices can be downloaded free from Google Play.  To date, there have been more than 50,000 downloads of BEP-sponsored mobile applications.

For additional information about the U.S. Currency Reader Program or our mobile apps, please visit BEP's website at http://www.bep.gov/resources/meaningfulaccess.html.  For more updates, follow us on Twitter and Facebook at @USMoneyfactory.

Contact: Lydia Washington
[email protected]
(202) 874-3487

SOURCE Bureau of Engraving and Printing


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: